Thu, 20 Aug 2026

November 23, 2022

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

Philippine central bank calls for Southeast Asian regulators to ‘step up’ vs financial, cybersecurity risks

Reshaping expectations in the Finance function

Singapore remains as centre hub for Southeast Asia M&A activities

PodChats for FutureCFO: AI in finance as a compliance imperative

Rewiring finance from expert to strategic partner

Where autonomous finance delivers measurable value

Subscribe